(Q33793937)

29 July 2017

1 reference

title

Review article: the efficacy of infliximab in Crohn's disease--healing of fistulae (English)

1 reference

29 July 2017

0 references

Present DH

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

Alimentary Pharmacology & Therapeutics

29 July 2017

published in

1 reference

29 July 2017

volume

13 Suppl 4

1 reference

29 July 2017

page(s)

23-8; discussion 38

1 reference

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00026.X

Efficacy of cyclosporine in treatment of fistula of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00026.X

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00026.X

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00026.X

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00026.X

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00026.X

10.1046/J.1365-2036.1999.00026.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference